Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy

被引：0
|
作者：
De Oliveira, Antonia [1 ]
Lei, Joyce [1 ]
Liu, Jiayuan [1 ]
Roche, Morgan [1 ]
Lin, Jerry [1 ]
Alfonso, Roberto [2 ]
Sadiq, Saud [1 ]
机构：
[1] Tisch Multiple Sclerosis Res Ctr New York, New York, NY USA
[2] Tisch Multiple Sclerosis, New York, NY USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202245
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S21.001
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Anti-CD20 antibody wows in multiple sclerosis
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2015, 33 (12) : 1215 - 1216
  • [42] Anti-CD20 antibody wows in multiple sclerosis
    Cormac Sheridan
    Nature Biotechnology, 2015, 33 : 1215 - 1216
  • [43] Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis
    Kim, John
    Kesselheim, Aaron S.
    Bove, Riley
    Avorn, Jerry
    Rome, Benjamin N.
    JAMA NEUROLOGY, 2024, 81 (01) : 85 - 87
  • [44] Treatment of multiple sclerosis with Anti-CD20 antibodies
    Barun, Barbara
    Bar-Or, Amit
    CLINICAL IMMUNOLOGY, 2012, 142 (01) : 31 - 37
  • [45] Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients
    Torgauten, Hilde M.
    Onyango, Therese Bredholt
    Ljostveit, Sonja
    Hallin, Erik I.
    Serkland, Trond T.
    Skrede, Silje
    Langeland, Nina
    Cox, Rebecca Jane
    Wergeland, Stig
    Myhr, Kjell-Morten
    Torkildsen, Oivind
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 89
  • [46] Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients
    Elgenidy, Anas
    Abdelhalim, Nagham Nader
    Al-kurdi, Mohammed Al-mahdi
    Mohamed, Lobna A.
    Ghoneim, Mohamed M.
    Fathy, Ahmed Wagdy
    Hassaan, Hazem Khaled
    Anan, Ahmed
    Alomari, Omar
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [47] Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Yoshioka, Satoshi
    Maruoka, Hayato
    Nasu, Seiko
    Nishioka, Tomomi
    Sakizono, Kenji
    Mitsuyuki, Satoshi
    Kubo, Tomoyo
    Okada, Naoki
    Nakagawa, Daishi
    Kamijo, Kimimori
    Imoto, Hiroharu
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Kondo, Tadakazu
    Miyakoshi, Chisato
    Doi, Asako
    Ishikawa, Takayuki
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [48] Evaluation of Risk Factors in Developing Lymphopenia and Hypogammaglobulinemia in Anti-CD20 Treated Multiple Sclerosis Patients
    Vollmer, Brandi
    Vollmer, Timothy
    Corboy, John
    Alvarez, Enrique
    NEUROLOGY, 2020, 94 (15)
  • [49] Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
    Masashi Nishikubo
    Yoshimitsu Shimomura
    Ryusuke Yamamoto
    Satoshi Yoshioka
    Hayato Maruoka
    Seiko Nasu
    Tomomi Nishioka
    Kenji Sakizono
    Satoshi Mitsuyuki
    Tomoyo Kubo
    Naoki Okada
    Daishi Nakagawa
    Kimimori Kamijo
    Hiroharu Imoto
    Yuya Nagai
    Nobuhiro Hiramoto
    Noboru Yonetani
    Tadakazu Kondo
    Chisato Miyakoshi
    Asako Doi
    Takayuki Ishikawa
    Blood Cancer Journal, 13
  • [50] Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Maruoka, Hayato
    Nasu, Seiko
    Sakizono, Kenji
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Kondo, Tadakazu
    Miyakoshi, Chisato
    Doi, Asako
    Ishikawa, Takayuki
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (03) : 821 - 825
12345